News & Resources
Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Poster 2020
On the performance of manually or automatically segmented DATSCAN-SPECT for biomarker extraction in PD
Advances in Alzheimer’s and Parkinson’s Therapies (AAT-ADPD) Poster 2020
Sleep-Wake Estimation From Actigraphy Data in Parkinson’s Disease: A Deep Learning Approach
"As clinical trials become more complex, we're seeing the [use of] medical imaging increasing" says Giulio Cerroni in S&P Global Market Intelligence interviewNew Blog Post
IXICO has been featured in S&P Global Market Intelligence's recently published article focused on use of AI technology in drug development. The article entitled 'Big Pharma recruits NASA scientist, sets up command centers in AI push' by Etain Lavelle was originally published here.
AMYPAD's interview with Katherine Gray, IXICO's associate director of technolog
IXICO's Associate Director of Technology, Katherine Gray was featured in AMYPAD's recent newsletter to highlight the work she and others within IXICO's tech & data management teams are doing to support AMYPAD projects, using our TrialTracker platform to improve the quality of imaging data.
CHDI Poster 2020
Fully-automatic AI segmentation of subcortical regions: comparison of ATLAS and deep-learning based approaches
Human Amyloid Imaging (HAI) Poster 2020
The Impact of Automatic Tau PET Processing On Uptake Variability and Power Analysis in AD
Human Amyloid Imaging (HAI) Poster 2020
Amyloid PET Variability due to Variation in MRI Protocol and Anatomical Segmentation
BGF investment fund's Paul Stevens: IXICO has “market leading position" & “impressive commercial traction”
The comments were made during the following Q&A session with Paul Stevens from BGF’s investment fund, who focuses on identifying opportunities among AIM-listed companies: 1. Can you provide some background on BGF and the sectors/types of companies you invest in?BGF was set up in 2011 to help support small growing companies in the UK.
81-88 of 155 results